LEVOCARNITINE
Generic: LEVOCARNITINE
ANI PharmaceuticalsManufacturer
ORALRoute
LEVOCARNITINEActive Substance
2019-08-14Original Approval
LEVOCARNITINE is FDA application ANDA211676, sponsored by NOVITIUM PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
SEIZURE
300 reports
2
OFF LABEL USE
273 reports
3
VOMITING
189 reports
4
DIARRHOEA
186 reports
5
DRUG INEFFECTIVE
165 reports
6
FATIGUE
155 reports
7
PYREXIA
148 reports
8
PNEUMONIA
144 reports
9
SOMNOLENCE
115 reports
10
PRODUCT DOSE OMISSION ISSUE
113 reports